Development and Translation of a Novel CRISPR Genome Editing Therapy to Induce Fetal Hemoglobin for Sickle Cell Disease

被引：0

作者：

Katta, Varun ^{[1
]}

Levine, Rachel M. ^{[1
]}

O'Keefe, Kiera ^{[1
]}

Li, Yichao ^{[1
]}

Dempsey, Erin A. ^{[1
]}

Nimmagadda, Nikitha ^{[1
]}

Jang, Yoonjeong ^{[1
]}

Mayberry, Kalin ^{[1
]}

Mayurathan, Thiyagaraj ^{[1
]}

Lazzarotto, Cicera R. ^{[1
]}

Wood, Rachael K. ^{[1
]}

Manquen, Garret ^{[1
]}

Powers, Alicia D. ^{[1
]}

Yao, Yu ^{[1
]}

Uchida, Naoya ^{[2
]}

Fazio, Frank ^{[1
]}

Lockey, Tim ^{[1
]}

Sharma, Akshay ^{[1
]}

Tisdale, John F. ^{[2
]}

Zhou, Sheng ^{[1
]}

Weiss, Mitchell J. ^{[1
]}

Yen, Jonathan S. ^{[1
]}

Tsai, Shengdar Q. ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN USA

[2] NIH, Bethesda, MD USA

来源：

MOLECULAR THERAPY | 2024年 / 32卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：2 / 3

页数：2

共 50 条

[21] Is Epigenetic Modulation to Induce Fetal Hemoglobin Translatable in Sickle Cell Mice?
Illa, Ariadna Carol
Petersen, Jesper
Skov, Soren
Glenthoej, Andreas
Ley, Carsten Dan
BLOOD, 2023, 142
[22] Unintended Consequences of CRISPR/Cas9-Mediated Genome Editing for Treating Sickle Cell Disease
Park, So Hyun
Pan, Yidan
Davis, Timothy
Deshmukh, Harshavardhan
Bao, Gang
MOLECULAR THERAPY, 2020, 28 (04) : 228 - 228
[23] Reactivation of fetal hemoglobin in thalassemia and sickle cell disease
Eridani, Sandro
Avemaria, Francesca
Mosca, Andrea
THALASSEMIA REPORTS, 2014, 4 (02) : 55 - 61
[24] Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
Metais, Jean-Yves
Doerfler, Phillip A.
Mayuranathan, Thiyagaraj
Bauer, Daniel E.
Fowler, Stephanie C.
Hsieh, Matthew M.
Katta, Varun
Keriwala, Sagar
Lazzarotto, Cicera R.
Luk, Kevin
Neel, Michael D.
Perry, S. Scott
Peters, Samuel T.
Porter, Shaina N.
Ryu, Byoung Y.
Sharma, Akshay
Shea, Devlin
Tisdale, John F.
Uchida, Naoya
Wolfe, Scot A.
Woodard, Kaitly J.
Wu, Yuxuan
Yao, Yu
Zeng, Jing
Pruett-Miller, Shondra
Tsai, Shengdar Q.
Weiss, Mitchell J.
BLOOD ADVANCES, 2019, 3 (21) : 3379 - 3392
[25] FETAL HEMOGLOBIN INDUCTION IN SICKLE CELL DISEASE AND THALASSEMIA
Thein, Swee Lay
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 15 - 15
[26] AMELIORATION OF SICKLE CELL DISEASE BY PERSISTENT FETAL HEMOGLOBIN
JACKSON, JF
BELL, WN
ODOM, JL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 177 (12): : 867 - &
[27] FETAL HEMOGLOBIN IN HOMOZYGOUS SICKLE-CELL DISEASE
SERJEANT, GR
CLINICS IN HAEMATOLOGY, 1975, 4 (01): : 109 - 122
[28] FETAL HEMOGLOBIN AND TREATMENT OF SICKLE-CELL DISEASE
LEVINE, EA
ROSEN, AL
SEHGAL, LR
GOULD, SA
MOSS, GS
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (02): : 118 - 118
[29] Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease
Campbell, Sean T.
CLINICAL CHEMISTRY, 2024, 70 (10) : 1298 - 1298
[30] Base Editing-Mediated Dissection of the-200 Region of the.Globin Promoters to Induce Fetal Hemoglobin and Rescue Sickle Cell Disease and ß-Thalassemia
Antoniou, Panagiotis
Hardouin, Giulia
Martinucci, Pierre
Felix, Tristan
Fontana, Letizia
Martin, Jeanne
Frati, Giacomo
Brusson, Megane
Rosello, Marion
Maule, Giulia
Del Bene, Filippo
Cereseto, Anna
El Nemer, Wassim
Concordet, Jean-Paul
Miccio, Annarita
BLOOD, 2021, 138

← 1 2 3 4 5 →